Neal Bhai Reports (NBR) — Cipla Rises On U.S. FDA Nod For Immunodeficiency Drug – Shares of the Mumbai-based drugmaker rose as much as 6.47 percent to Rs 622.75 after U.S. FDA gave its final approval to Efavirenz tablets in strength of 600 mg. Efavirenz Tablets 600 mg is AB-rated generic therapeutic equivalent version of Bristol-Myers Squibb Pharma Company’s Sustiva which is used in treatment of human immunodeficiency virus type 1 infection, Cipla said in an exchange filing.
free stock market tips for tomorrow
Bond Yield Drops On Reserve Bank’s OMO Plan
Bond Yield Drops On Reserve Bank’s OMO Plan – Yield on India’s 10-year 7.17 percent bond expiring in January 2028 dropped 4 basis points to 7.82 percent after the Reserve Bank of India said it will buyback Rs 10,000 crore of debt via open market operations (OMO) on Thursday, the first …
Stocks Check : Cipla, State Bank Of India And More
Stocks Check: Cipla, State Bank Of India And More 📌 State Bank of India won’t be able to merge more banks with self. 📌 UPL-led consortium is in exclusive talks to acquire Bill Ackman-backed Platform Specialty Products Corp. 📌 Cipla gets final approval for generic drug Sustiva. 📌 The wealth management …
Indian Stock Market Is Driven By Traders From One City
Gold Silver Reports (GSR) – Indian Stock Market Is Driven By Traders From One City – A record number of Indians now have demat accounts but India remains a traders’ stock market driven by one city: Mumbai.
Pokarna Declines After Well Known Investor Sells Stake
Gold Silver Reports (GSR) – Pokarna Declines After Well Known Investor Sells Stake – Shares of the Secunderabad-based company engaged in business of granite quarrying fell as much as 3 percent to Rs 174.50 after well-known investor Ashish Kacholia sold 1.2 percent stake in the company.
Vedanta Set For Its Longest Losing Streak In Over Three Months
Gold Silver Reports (GSR) – Vedanta Set For Its Longest Losing Streak In Over Three Months – Shares of the metal maker extended its decline for the seventh straight session today, its longest losing streak since March 9. The stock fell as much as 3.3 percent to hit a 52-week low at Rs 230.65 apiece.
BSE Drops Two Pharma Stocks From Sensex; Replaces Them With Private Banks
Gold Silver Reports (GSR) – BSE Drops Two Pharma Stocks From Sensex; Replaces Them With Private Banks – The S&P BSE Sensex will include two more banks from mid-Dec. while two pharmaceutical stocks will exit the index.
Pc Jeweller Stock Price Above 162, We Expect Big Blast Hint Call By Neal Bhai Reports
Pc Jeweller Stock Price Above ₹ 162, We Expect Big Blast Hint Call By Neal Bhai Reports
“No Magic, No Miracle, Just Power of Level”
Neal Bhai Reports (NBR) By CFA’s and MFA’s Technical Team
Mobile No. 9582247600 & 9899900589
Bajaj Finance Share Price Below 2222, Only Down Down Down Tips By Neal Bhai Reports
Bajaj Finance Share Price Below 2222, Only Down Down Down Tips By Neal Bhai Reports
“No Magic, No Miracle, Just Power of Level”
Neal Bhai Reports (NBR) By CFA’s and MFA’s Technical Team
Mobile No. 9582247600 & 9899900589
Stocks To Watch – After Interest-Rate Hike By Neal Bhai Reports INDIA
HDFC Bank: Cabinet approves raising of additional share capital of HDFC Bank up to a maximum of Rs 24,000 crore. The Cabinet Committee on Economic Affairs today allowed an additional Rs 24,000 crore foreign direct investment into private sector lender HDFC Bank.